Novel substituted heteroaromatic compounds as inhibitors of stearoyl-CoA desaturase

Bibliography

• Chavez JA, Summers SA. Lipid oversupply, selective insulin resistance, and lipotoxicity: Molecular mechanisms. Biochim Biophys Acta 2010;18(1):252-65
   Google Scholar
• Cohen P, Miyazaki M, Socci ND, Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 2002;297:240-3
   PubMed Web of Science ®Google Scholar
• Dobrzyn A, Ntambi JM. The role of stearoyl-CoA desaturase in body weight regulation. Trends Cardiovasc Med 2004;14:77-81
   PubMed Web of Science ®Google Scholar
• Ntambi JM, Buhrow SA, Kaestner KH, Differentiation-induced gene expression in 3T3-L1 preadipocytes. Characterization of a differentially expressed gene encoding stearoyl-CoA desaturase. J Biol Chem 1988;263:17291-300
   PubMed Web of Science ®Google Scholar
• Kaestner KH, Ntambi JM, Kelly TJ, Differentiation-induced gene expression in 3T3-L1 preadipocytes. A second differentially expressed gene encoding stearoyl-CoA desaturase. J Biol Chem 1989;264:14755-61
   PubMed Web of Science ®Google Scholar
• Zheng Y, Prouty SM, Harmon A, Scd3: a novel gene of the stearoyl-CoA desaturase family with restricted expression in skin. Genomics 2001;71:182-91
   PubMed Web of Science ®Google Scholar
• Miyazaki M, Jacobson MJ, Man WC, Identification and characterization of murine SCD4, a novel heart-specific stearoyl-CoA desaturase isoform regulated by leptin and dietary factors. J Biol Chem 2003;278:33904-11
   PubMed Web of Science ®Google Scholar
• Zhang L, Ge L, Parimoo S, Human stearoyl-CoA desaturase: alternative transcripts generated from a single gene by usage of tandem polyadenylation sites. Biochem J 1999;340:255-64
   PubMed Web of Science ®Google Scholar
• Beiraghi S, Zhou M, Talmadge CB, Identification and characterization of a novel gene disrupted by a pericentric inversion inv(4)(p13.1q21.1) in a family with cleft lip. Gene 2003;309:11-21
   PubMedGoogle Scholar
• Dobrzyn P, Dobrzyn A. Stearoyl-CoA desaturase: a new therapeutic target of liver steatosis. Drug Dev Res 2006;67:643-50
   Google Scholar
• Dobrzyn P, Ntambi JM, Dobrzyn A. Stearoyl-CoA desaturase: A novel control pint of lipid metabolism and insulin sensitivity. Eur J Lipid Sci Technol 2008;110:93-100
   Web of Science ®Google Scholar
• Paton CM, Ntambi JM. Biochemical and physiological function of stearoyl-CoA desaturase. Am J Physiol Endocrinol Metab 2009;297:E28-37
   PubMed Web of Science ®Google Scholar
• Rahman SM, Dobrzyn A, Dobrzyn P, Stearoyl-CoA desaturase 1 deficiency elevates insulin-signaling components and down-regulates protein-tyrosine phosphatase 1B in muscle. Proc Natl Acad Sci USA 2003;100:11110-5
   PubMed Web of Science ®Google Scholar
• Dobrzyn P, Sampath H, Dobrzyn A, Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart. Am J Physiol Endocrinol Metab 2008;294:E357-64
   Google Scholar
• MacDonald ML, Singaraja RR, Bissada N, Absence of stearoyl-CoA desaturase-1 ameliorates features of the metabolic syndrome in LDLR-deficient mice. J Lipid Res 2008;49:217-29
   Google Scholar
• Miyazaki M, Dobrzyn A, Sampath H, Reduced adiposity and liver steatosis by stearoyl-CoA desaturase deficiency are independent of peroxisome proliferator-activated receptor-alpha. J Biol Chem 2004;279:35017-24
   PubMed Web of Science ®Google Scholar
• Miyazaki M, Flowers MT, Sampath H, Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosos. Cell Metab 2007;6:484-96
   PubMed Web of Science ®Google Scholar
• Sampath H, Flowers MT, Liu X, Skin-specific deletion of stearoyl-CoA desaturase-1 alters skin lipid composition and protects mice from high fat diet-induced obesity. J Biol Chem 2009;284:19961-73
   PubMed Web of Science ®Google Scholar
• Dobrzyn P, Dobrzyn A, Miyazaki M, Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver. Proc Natl Acad Sci USA 2004; 101:6409-14
   PubMed Web of Science ®Google Scholar
• Dobrzyn A, Dobrzyn P, Lee SH, Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle. Am J Physiol Endocrinol Metab 2005;288:E599-607
   PubMed Web of Science ®Google Scholar
• Lee SH, Dobrzyn A, Dobrzyn P, Lack of stearoyl-CoA desaturase 1 upregulates basal thermogenesis but causes hypothermia in a cold environment. J Lipid Res 2004;45:1674-82
   PubMed Web of Science ®Google Scholar
• Miyazaki M, Dobrzyn A, Man WC, Stearoyl-CoA desaturase 1 gene expression is necessary for fructose-mediated induction of lipogenic gene expression by sterol regulatory element-binding protein-1c-dependent and -independent mechanisms. J Biol Chem 2004;279:25164-71
   PubMed Web of Science ®Google Scholar
• Dobrzyn A, Dobrzyn P, Miyazaki M, Stearoyl-CoA desaturase 1 deficiency increases CTP:choline cytidylyltransferase translocation into the membrane and enhances phosphatidylcholine synthesis in liver. J Biol Chem 2005;280:23356-62
   Google Scholar
• Ntambi JM, Miyazaki M, Stoehr JP, Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci USA 2002;99:11482-6
   PubMed Web of Science ®Google Scholar
• Dobrzyn P, Jazurek M, Dobrzyn A. Stearoyl-CoA desaturase and insulin signaling – what is the molecular switch? Biochim Biophys Acta 2010; published online 7 February 2010,doi:10.1016/j.bbabio.2010.02.007
   Google Scholar
• Flowers JB, Rabaglia ME, Schueler KL, Loss of stearoyl-CoA desaturase-1 improves insulin sensitivity in lean mice but worsens diabetes in leptin-deficient obese mice. Diabetes 2007;56:1228-39
   Google Scholar
• Asilmaz E, Cohen P, Miyazaki M, Site and mechanism of leptin action in a rodent form of congenital lipodystrophy. J Clin Invest 2004;113:414-24
   PubMed Web of Science ®Google Scholar
• Warensjö E, Ingelsson E, Lundmark P, Polymorphisms in the SCD1 gene: associations with body fat distribution and insulin sensitivity. Obesity 2007;15:1732-40
   Google Scholar
• Yao-Borengasser A, Rassouli N, Varma V. Stearoyl-coenzyme A desaturase 1 gene expression increases after pioglitazone treatment and is associated with peroxisomal proliferator-activated receptor-gamma responsiveness. J Clin Endocrinol Metab 2008;93:4431-9
   PubMedGoogle Scholar
• Attie AD, Krauss RM, Gray-Keller MP, Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia. J Lipid Res 2002;43:1899-907
   PubMed Web of Science ®Google Scholar
• Kamboj R, Zhang Z, Fu J, Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase. WO2006034338; 2006
   Google Scholar
• Zhao H, Serby MD, Smith HT, Discovery of 1-(4-phenoxypiperidin-1-yl)-2-arylaminoethanone stearoyl-CoA desaturase 1 inhibitors. Bioorg Med Chem Lett 2007;17:3388-91
   PubMed Web of Science ®Google Scholar
• Liu G, Lynch JK, Freeman J. Discovery of potent, selective, orally bioavailable stearoyl-CoA desaturase 1 inhibitors. J Med Chem 2007;50:3086-100
   PubMed Web of Science ®Google Scholar
• Dobrzyn A, Dobrzyn P. Inhibition of stearoyl-CoA desaturase by cyclic amine derivatives. Expert Opin Ther Patents 2008;18:457-60
   Web of Science ®Google Scholar
• Liu G. Stearoyl-CoA desaturase inhibitors: update on patented compounds. Expert Opin Ther Patents 2009;19:1169-91
   PubMed Web of Science ®Google Scholar
• Binczek E, Jenke B, Holz B, Obesity resistance of the stearoyl-CoA desaturase-deficient (scd1-/-) mouse results from disruption of the epidermal lipid barrier and adaptive thermoregulation. Biol Chem 2007;388:405-18
   PubMed Web of Science ®Google Scholar
• Chen C, Shah YM, Morimura K, Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis. Cell Metab 2008;7:135-47
   PubMed Web of Science ®Google Scholar